Sanjivani Paranteral Ltd. benchmarking: Performance to industry peers

Financial

	Sanjivani Paranteral	Guj. Inject (Kerala)	Bio Medica Labs.
Operational Metrics
Pharmaceuticals
Quarterly Sales Volume - Injectables	n/a	n/a	n/a
Quarterly Sales Volume - Orals	n/a	n/a	n/a
Quarterly Sales Volume - Nutraceuticals	n/a	n/a	n/a
Financials
5 yr Average ROE	14.47 %	2.58 %	43.58 %
5yr average Equity Multiplier	-1.07	0.11	4.59
5yr Average Asset Turnover Ratio	1.28	0.45	0.9
5yr Avg Net Profit Margin	11.86 %	-175.28 %	14.7 %
Price to Book	3.71	15.22	0.0
P/E	26.4	99.23	18.5
5yr Avg Cash Conversion Cycle	9.84 Days	-14.62 Days	34.88 Days
Inventory Days	50.77 Days	38.61 Days	114.83 Days
Days Receivable	53.66 Days	0.0	30.75 Days
Days Payable	138.53 Days	156.02 Days	279.97 Days
5yr Average Interest Coverage Ratio	21.37	298.1	5.69
5yr Avg ROCE	-90.78 %	2.0 %	39.6 %
5yr Avg Operating Profit Margin	14.73 %	-279.73 %	29.22 %
5 yr average Debt to Equity	-0.19	-0.62	2.36
5yr CAGR Net Profit	12.42 %	n/a	96.99 %
5yr Average Return on Assets	15.34 %	-116.01 %	13.32 %
Shareholdings
Promoter Holding	31.26 %	0.0	n/a
Share Pledged by Promoters	0.0	0.0	n/a
Change in Promoter Holding (3 Yrs)	1.38 %	0.0	n/a
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	n/a

	Sanjivani Paranteral	Guj. Inject (Kerala)	Bio Medica Labs.
Product Wise Break-Up	Product Wise Break-Up Injectables 50.0 Tablets 42.6 Nutraceuticals 7.4 Liquid injections 0 Dry powder injection 0	Product Wise Break-Up Tablets 0 Nutraceuticals 0 Liquid injections 0 Injectables 0 Dry powder injection 0 Others 100	Product Wise Break-Up Tablets 0 Nutraceuticals 0 Liquid injections 63.96 Injectables 0 Dry powder injection 35.14 Others 0.9
Location Wise Break-Up	Location Wise Break-Up Middle East & Africa 41.2 Latin America 29.4 India 28.0 CIS Countries 1.4 Afghanistan 0	-	Location Wise Break-Up CIS Countries 0 Afghanistan 0 Latin America 0 India 100.0 Middle East & Africa 0